U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07378072) titled 'Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity' on Dec. 11, 2025.
Brief Summary: The objective of this study is to demonstrate that an < or equal to 8-hour time-restricted eating (i.e., fasting for at least 16 hours every day), not focusing on reducing caloric intake, reduces intra-hepatic fat in patients with obesity and Metabolic dysfunction-Associated Steatotic liver Disease (MASLD).
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
Intervention:
BEHAVIORAL: Time Restricted Eating
Coaching of the patient by a di...